Papers

26

Total Citations

1,667

H-Index

16

About

Jeffrey S. Montgomery is a pioneering urologic surgeon whose research has fundamentally reshaped the surgical management of genitourinary cancers, particularly through high-impact, practice-defining clinical trials. His landmark contribution is the RAZOR trial, a phase 3, non-inferiority study that established robot-assisted radical cystectomy as a safe and effective alternative to open surgery for bladder cancer, accumulating over 760 citations and influencing global surgical standards. Montgomery’s work extends beyond bladder cancer to include the development of objective assessment tools for robotic prostatectomy and the validation of robotic techniques for retroperitoneal lymph node dissection in testicular cancer and minimally invasive inguinal lymphadenectomy for penile carcinoma. His research consistently addresses critical questions of oncologic efficacy, perioperative outcomes, and surgical skill acquisition, with multiple studies garnering over 100 citations. By combining rigorous methodology with a focus on translating robotic technology into improved patient outcomes, Montgomery has become a leading voice in evidence-based robotic urologic oncology, directly guiding how surgeons approach complex, high-stakes procedures.

Research Focus

Key Achievements

16
H-Index
26
Papers
1,667
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
760 citations · 2018
📈 Most Prolific Year: 2016 (4 Papers)
🤝 Key Collaborators: 136
🏛 Institutions: University of Michigan–Ann Arbor, Michigan Medicine, Ann Arbor Center for Independent Living

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago